SCHEMBL24239199

SCHEMBL24239199

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5ccc6c(c5)oc5c7ccccc7ccc65)cc34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 12/20 0.43
▸ CYP1B1 Q16678 11/20 0.43
▸ CYP1A2 P05177 11/20 0.43
▸ HPGD P15428 4/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ TSHR P16473 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ PRKDC P78527 3/20 0.43
▸ ABCG2 Q9UNQ0 3/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ PDE5A O76074 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ ABCB1 P08183 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2B6 P20813 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26597983 0.94 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL25460315 0.94 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL19916927 0.94 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL24222244 0.93 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL23154928 0.93 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL19916944 0.92 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL22071476 0.92 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL25132059 0.92 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL25557617 0.92 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2HPGDKDM4E
SCHEMBL27454653 0.92 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 — — US disclosed
US-20220037594-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 CYP1A1 897/4885CYP1B1 2461/4885CYP1A2 762/4885
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof PIEZO1, ORAI2, OCIAD1 CYP1A1 787/4885CYP1B1 1728/4885CYP1A2 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback